Considerable Number of Abortion Seekers Accessed Services After Dobbs
By Elana Gotkine HealthDay Reporter
MONDAY, March 25, 2024 -- Despite implementation of state-level bans and restrictions on abortion after the Supreme Court decision in Dobbs v. Jackson Women's Health Organization, which overturned the right to choose abortion in the United States, a considerable number of abortion seekers accessed services in the six months after Dobbs, according to a study published online March 25 in the Journal of the American Medical Association.
Abigail R.A. Aiken, Ph.D., from the University of Texas at Austin, and colleagues examined whether the provision of medications for self-managed abortion outside the formal health care setting increased in the six months after Dobbs. The cross-sectional study used data from sources that provide abortion medications outside the formal health care setting between March 1 and Dec. 31, 2022.
The researchers found that in the six-month post-Dobbs period (July 1 to Dec. 31, 2022), there was an increase of 27,838 in the total number of provisions of medications for self-managed abortion compared with what would have been expected based on pre-Dobbs levels. The results changed slightly when excluding imputed data (27,145). There was an estimated increase of 26,055 in actual self-managed medication abortions compared with what would have been expected had the Dobbs decision not occurred, after accounting for nonuse of medications.
"Provision of medications for self-managed abortions increased in the six months following the Dobbs decision," the authors write. "Results suggest that a substantial number of abortion seekers accessed services despite the implementation of state-level bans and restrictions."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
Mail-Order Mifepristone Effective, Feasible for Medication Abortion
MONDAY, May 13, 2024 -- Mail-order pharmacy dispensing of mifepristone for medication abortion is effective, acceptable, and feasible, according to a study published online May 13...
2020 to 2021 Saw Nonsignificant Decline in Perinatal Mortality Rate
THURSDAY, Dec. 7, 2023 -- A nonsignificant decline was seen in the U.S. perinatal mortality rate from 2020 to 2021, according to a December data brief published by the U.S...
CDC: 2020 to 2021 Saw Rise in Total Number, Rate, Ratio of Abortions
WEDNESDAY, Nov. 22, 2023 -- From 2020 to 2021, there were increases in the total number, rate, and ratio of reported abortions, according to research published in the Nov. 24...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.